Research Article
Clinical Outcomes of Ileostomy Closure during versus after Adjuvant Chemotherapy in Patients with Rectal Cancer
Table 2
Data related to ileostomy closure.
| | | Group A | Group B | value | | (n = 115), (%) | (n = 100), (%) |
| | Interval to ileostomy closure (day; IQR) | 98 (83–110) | 179 (152–211) | <0.001 | | Operation time (min) | 87.41 ± 34.29 | 91.21 ± 37.99 | 0.442 | | Blooding loss (mL) | 23.77 ± 16.72 | 25.15 ± 17.89 | 0.558 | | Time to first flatus (day) | 3.28 ± 1.08 | 3.22 ± 0.92 | 0.673 | | Time to fully oral nutrition (day) | 3.30 ± 1.08 | 3.32 ± 1.13 | 0.872 | | Hospital stay (day) | 5.17 ± 1.87 | 5.31 ± 1.68 | 0.558 | | Postoperative complications | 18/115 (15.7%) | 22/100 (22.0%) | 0.102 | | Clavien–Dindo classification | | | | | Grade I | 8 (7.0%) | 8 (8.0%) | | | Grade II | 2 (1.7%) | 10 (10.0%) | | | Grade IIIa | 2 (1.7%) | 1 (1.0%) | | | Grade IIIb | 6 (5.2%) | 3 (3.0%) | | | Chemotherapy regimens | | | 0.686 | | Monotherapy | 22 | 17 | | | Combined chemotherapy | 93 | 83 | | | Postoperative infection | 2 (1.7%) | 4 (4.0%) | 0.315 | | Cost (yuan) | 39613.28 ± 11004.39 | 37142.76 ± 12427.55 | 0.124 | | Increased creatinine (μmol/L) | 8.43 ± 31.26 | 4.95 ± 14.73 | 0.309 | | Decreased BMI (kg/m2) | 0.91 ± 1.71 | 0.67 ± 1.46 | 0.275 | | Anastomotic evaluation method | | | | | Endoscope | 99 (86.1%) | 91 (91.0%) | 0.262 | | Endoscope + CT | 74 (64.3%) | 69 (69.0%) | 0.471 | | Rectal anastomosis stenosis | 14 (12.2%) | 23 (23.0%) | 0.036 | | Disused colitis | 29 (25.2%) | 25 (25%) | 0.971 | | Chemotherapy cycles (times) | 5.19 ± 1.53 | 5.72 ± 1.41 | 0.009 | | Follow-up time (IQR) | 36 (28–47) | 36 (29–51) | 0.393 | | Postoperative regular follow-up | 78 (67.8%) | 66 (66.0%) | 0.726 |
|
|
IQR, interquartile range; BMI, body mass index; CT, computed tomography; . |
